Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Johnson and Johnson
Cantor Fitzgerald
McKinsey
Medtronic
Daiichi Sankyo
Deloitte
Cerilliant

Generated: April 24, 2018

DrugPatentWatch Database Preview

XIBROM Drug Profile

« Back to Dashboard

Which patents cover Xibrom, and what generic alternatives are available?

Xibrom is a drug marketed by Bausch And Lomb Inc and is included in one NDA.

The generic ingredient in XIBROM is bromfenac sodium. Four suppliers are listed for this compound. Additional details are available on the bromfenac sodium profile page.
Summary for XIBROM
Drug patent expirations by year for XIBROM
Pharmacology for XIBROM
Synonyms for XIBROM
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
{2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid
120638-55-3
2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid
2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
2-[2-amino-3-[(4-bromophenyl)-oxomethyl]phenyl]acetic acid
2-[2-azanyl-3-(4-bromophenyl)carbonyl-phenyl]ethanoic acid
2-{2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid
2-Amino-3-(4-bromobenzoyl)benzeneacetic acid
27R
4CH-007116
4mjq
638B553
864P0921DW
91714-93-1 (Na salt)
91714-94-2
A844048
AB0027651
AC1L1TSW
AC1Q5DQ7
AHR 10282
AHR-10282
AHR-10282B
AJ-41875
AK-85648
AKOS015998697
Ambap120638-55-3
AN-5545
ANW-47053
API0009095
AX8118731
Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-
Benzeneacetic acid,2-amino-3-(4-bromobenzoyl)-
Bromday
Bromfenac
Bromfenac (INN)
Bromfenac [INN]
Bromfenaco
Bromfenaco [Spanish]
Bromfenacum
Bromfenacum [Latin]
C-23660
C15H12BrNO3
CC-25212
CHEBI:240107
CHEMBL1077
CTK8B5019
D07541
D0U1OM
DA-01153
DB00963
DR001600
DTXSID7040655
Duract
Duract (TN)
EBD87057
EBD898487
FT-0710423
GS-3830
GTPL7131
ISV-303
J-519935
KB-295409
KS-00000FTU
LS-178156
MFCD00864341
MLS004774052
MolPort-000-883-091
MP-1093
OR372232
Prolensa
SCHEMBL34411
SMR003500721
SR-01000941476
SR-01000941476-2
ST24027466
TC-135798
UNII-864P0921DW
W9506
Xibrom (TN)
Yellox
ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
ZINC2570817

US Patents and Regulatory Information for XIBROM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb Inc XIBROM bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 021664-001 Mar 24, 2005 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Healthtrust
Express Scripts
QuintilesIMS
Covington
US Department of Justice
Fish and Richardson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.